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WE have studied the effect of human recombinant tumour
necrosis factor-t (TNF-t) on gene expression and produc-
tion of endothelin-1 in cultured bovine aortic endothelial
cells. TNF-0t (10 and 100 ng m1-1) increased in a time
dependent manner the preproendothelin-1 mRNA levels
in respect to unstimulated endothelial cells. TNF-t in-
duced endothelin-1 gene expression was associated with
a parallel increase in the release of the corresponding
peptide in the culture medium. These findings suggest
that the enhanced synthesis and release of endothelin-1
occurring in conditions of increased generation of TNF,
may act as a modulatory factor that counteracts the hypo-
tensive effect and the excessive platelet aggregation and
adhesion induced by TNF.
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Introduction
Humoral, neural and mechanical stimuli can
induce endothelium dependent vasoconstriction
through the release of vasoactive substances
from endothelial cells.
Recently, the endothelins, a family of 21-
aminoacid peptides isolated and purified from
endothelial cells,
2 have been recognized as potent
vasoconstrictors of mammalian blood vessels.
Stimulation of preproendothelin-1 gene expression
in cultured endothelial cells by thrombin, trans-
forming growth factor fl, interleukin-1 and shear
stress with subsequent release of the active peptide
in the culture medium,2’4-6 implies that endothelial
cell perturbation or injury may be associated with
a local release of endothelin that is likely to play an
active role in the process of tissue injury and repair.
This is in keeping with the recent discovery that
endotoxin, a noxious agent for endothelial cells,7’8
stimulates endothelin release in vitro and in vivo.
9
Studies in the last few years have convincingly
documented that most of the effects of endotoxin
infusion into experimental animals are mediated by
turnout necrosis factor (TNF), a macrophage-
derived peptide with potent biological activities. 1’11
When infused into normal rabbits TNF induced
glomerular changes remarkably similar to those
found in animals given endotoxin,
12 that included
endothelial cell damage, polymorph accumulation
and fibrin formation.
3
The present study was designed to investigate
whether human recombinant TNF- modifies
preproendothelin-1 gene expression in cultured
bovine aortic endothelial cells, and whether changes
(C) 1992 Rapid Communications of Oxford ktd
in endothelin gene expression are associated with
the release of the corresponding peptide in the cell
supernatant.
Materials and Methods
Endothelial cell culture and incubation: Bovine aortic
endothelial cells were obtained by collagenase
digestion and cultured as previously described.4
Cells were identified as endothelial by their
cobblestone appearance in monolayer and the
presence of factor VIII antigen by using indirect
immunofluorescence microscopy.
5
Confluent cells (passage 1-2) grown in 100 mm
plastic dishes were incubated for 1, 2 or 6h at
37C in 5 ml D-MEM (Gibco, Grand Island, NY)
with 1% foetal calf serum (Hyclone, Logan, UT) in
the absence or presence of human recombinant
TNF-0 (10 and 100 ng ml-1). Human recombinant
TNF-z (Cetus Corp., Emeryville, CA) had a specific
activity of 107 U mg- of protein and was virtually
endotoxin free (<0.3 pg endotoxin /g- by the
Limulus amoebocyte lysate assay). At the end of the
incubation, the supernatants were collected for
endothelin-1 measurement and the cells were used
for total cellular RNA preparation.
Preparation oftotal cellularRNA and Northern blot analysis:
Total cellular RNA was isolated from endothelial
cells by lysing cells in guanidium isothiocyanate and
recovering RNA by centrifugation through caesium
chloride.
16 RNA (10/zg) was then fractionated on
a 1.2% agarose gel with 6% formaldehyde and
blotted onto synthetic membranes (Gene Screen
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Plus, New England Nuclear).
17 Human pre-
proendothelin-1 probe,
17 was labelled to a specific
activity of 109 cpm/g-1 by using hexanucleotide
primers and 32p-dCTP.18 Hybridization was per-
formed for 20 h at 60C17 and the membranes were
washed as previously described. 17 Membranes were
subsequently rehybridized with a mouse o-actin
cDNA
19 to determine an internal standard of total
RNA content. Following optimal exposure, the
autoradiographs of each experiment were scanned
by a laser densitometer in order to quantify the
relative amounts of radioactively labelled probe
bound for each transcript. Endothelin mRNA
optical density was normalized to that of the
constituently released mouse actin gene expres-
sion.
Radioimmunoassay for endothelin: Unextracted samples
were assayed at appropriate dilutions in phosphate
buffer (pH 7.2) containing 0.1% Triton X-100 and
0.3% albumin (RIA buffer) as previously de-
scribed. 17 Results were expressed as pg 10
-6 cells.
The minimum detectable concentration that could
be measured was 0.4pg per tube. The cross
reactivity of the antibody with other endothelins is
as follows: endothelin-2, 46.9%; endothelin-3, 17%;
and big endothelin-1, 9.4%.
iv
Statistical analysis" Results of endothelin production
are expressed as mean -t- SD. Statistical analysis was
performed by using two-way analysis of variance
by Tukey’s test. Statistical significance level was
defined as p < 0.05.
Results and Discussion
We first determined whether the expression of
the preproendothelin-1 gene in bovine aortic
endothelial cells is stimulated by TNF-0. To this
purpose we monitored by Northern blot analysis
endothelin-1 mRNA levels in endothelial cells
exposed for 1, 2 and 6h to two different
concentrations of TNF-0. As shown in Figure 1
(panel A), TNF- at the concentration of
10 ng m1-1 increased in a time dependent manner
the preproendothelin-1 mRNA levels in respect to
unstimulated endothelial cells. Analysis of the
optical density of the autoradiographic signals
(Figure 1, panel B) indicated an increase of
preproendothelin-1 mRNA levels ranging 1.9-2.6
fold over the basal levels within 6 h. Incubation of
endothelial cells with a higher concentration of
TNF-0, 100 ng ml-1, reproduced the pattern
observed with 10ng ml-1 TNF-0 without a
further stimulation of endothelin-1 transcript
(Figure 2, Table 1).
Next we sought to establish whether the increase
of endothelin gene expression elicited by TNF-0 in
bovine aortic endothelial cells was associated with
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FIG. 1. Panel A: Endothelin-1 mRNA expression in BAEC incubated for
1, 2 and 6h with medium alone or 10ngm1-1 TNF-. The same
membrane was rehybridized to the actin probe. Blots are representative
of four individual experiments. Panel B: Corresponding densitometry of
the autoradiograph reported in Panel A. The optical density of the
autoradiography signals was quantitated and calculated as the ratio of
endothelin to actin mRNA. The mRNA level of unstimulated BAEC
(control) was assigned the number 1.0 and all other values were
calculated relative to that value.
increased synthesis and release of the endothelin-1
peptide in the cell supernatants. Figure 3 shows
endothelin-1 production, measured by a specific
radioimmunoassay, in supernatants of endothelial
cells incubated for 1, 2 and 6 h with medium alone
(control) or TNF-0 at concentrations of 10 and
100 ng ml-1. Endothelin-1 production in super-
natants of endothelial cells exposed to TNF-0 forTNF stimulates endothelin-1 gene expression
FIG. 2. Panel A: Endothelin-1 mRNA expression in BAEC exposed for 1,
2 and 6h to medium alone or 100ngm1-1 TNF-. Blots are
representative of four individual experiments. Panel B: Corresponding
densitometry of the autoradiograph reported in Panel A.
Table 1. Endothelin gene expression in bovine aortic
endothelial cells after TNF stimulation
Incubation time
lh 2h 6h
TNF 10 ng/ml 1.92 4- 0.14 2.18 4- 0.31 2.59 -t- 0.34
TNF 100 ng/ml 1.72 + 0.10 2.02 4- 0.14 2.55 4- 0.30
Values are means 4- SD (n 4).
The ratio of endothelin/actin optical density of four individual
experiments was calculated relative to endothelin/actin ratio in
unstimulated cells. Control ratio was assigned the number 1.0
and all other values were calculated relative to that value.
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FIG. 3. Endothelin-1 production in supernatants of BAEC incubated for
1,2 and 6 h with medium alone (control) orTNF- (10 and 100 ng ml-1).
Endothelin measured in a media blank was 0.5 ___
0.2 pg m1-1. Values are
expressed as mean 4- SD.*p < 0.05; **p < 0.01 versus control BAEC.
1 h showed a trend to increase compared to
unstimulated cells. After 2 h incubation of en-
dothelial cells with 10 ng ml- TNF-z, endothelin-
1 production was numerically higher than control
values, but the difference did not reach statistical
significance. The level of endothelin-1 increased
to a statistically significant (p<0.05) extent
when endothelial cells were exposed for 2 h to
100ngml-1 TNF-0, as compared with cells
incubated with medium alone. A further and
significant (p < 0.01) increase in endothelin pro-
duction in respect to unstimulated cells was
observed when endothelial cells were incubated
with TNF-z for 6 h, without significant differences
between 10 or 100 ng ml- TNF-.
Altogether these findings show that TNF<z
increases endothelin-1 gene expression in bovine
endothelial cells and that TNF-0 induced en-
dothelin-1 gene expression is associated with a
parallel increase in the release of the corresponding
peptide in the culture medium. The apparent weak
action of TNF<z, as compared to other stimuli,
suggests that this cytokine acts as a mild
transcriptional activator of the endothelin-1 gene.
4-6
The central role ofTNF- in the pathogenesis of
septic shock and the capacity for TNF- to induce
profound alterations of endothelial cell function has
been well documented.
2 It has been recognized
recently that the endothelium contributes to the
control of vascular tone by releasing vasodilators,
including endothelium-derived relaxing factor
(EDRF), nitric oxide (NO),
2 and vasoconstrictors
such as endothelin. Thus, TNF-0 induces NO
synthase activity in bovine aortic endothelial cells
in culture, and the consequent release of NO,
22
which largely accounts for hypotension
2>25 and
acute renal failure
13 induced by TNF in vivo. The
release of endothelin observed after exposure of
endothelial cells to TNF-o may be considered an
additional modulator of vascular tone at a
systemic2<27 and renal level.
28-3
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On the other hand endothelin, besides its potent
vasoactive properties also inhibits local platelet
aggregation in vivo.3 It is therefore conceivable that
the enhanced synthesis and release of endothelin in
response to TNF contribute to counteracting
excessive platelet activation in the microcirculation
upon challenge with stimuli, such as endotoxin, that
promote the release of TNF.
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